A detailed history of Pineridge Advisors LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Pineridge Advisors LLC holds 527 shares of JNJ stock, worth $76,557. This represents 0.03% of its overall portfolio holdings.

Number of Shares
527
Previous 598 11.87%
Holding current value
$76,557
Previous $87.4 Million 2.25%
% of portfolio
0.03%
Previous 0.03%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

SELL
$145.48 - $167.38 $10,329 - $11,883
-71 Reduced 11.87%
527 $85.4 Million
Q2 2024

Jul 25, 2024

SELL
$144.38 - $157.78 $9,529 - $10,413
-66 Reduced 9.94%
598 $87.4 Million
Q1 2024

May 16, 2024

SELL
$155.22 - $162.74 $87,699 - $91,948
-565 Reduced 45.97%
664 $105 Million
Q4 2023

Mar 01, 2024

BUY
$145.6 - $158.88 $178,942 - $195,263
1,229 New
1,229 $193 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $380B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Pineridge Advisors LLC Portfolio

Follow Pineridge Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pineridge Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pineridge Advisors LLC with notifications on news.